Year |
Citation |
Score |
2015 |
Yan L, Silva DM, Verma B, Gray A, Brand HE, Skeate JG, Porras TB, Kanodia S, Kast WM. Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes. The Prostate. 75: 280-91. PMID 25399517 DOI: 10.1002/Pros.22914 |
0.566 |
|
2010 |
Gray A, Yan L, Kast WM. Prevention is better than cure: the case for clinical trials of therapeutic cancer vaccines in the prophylactic setting. Molecular Interventions. 10: 197-203. PMID 20729485 DOI: 10.1124/mi.10.4.2 |
0.486 |
|
2009 |
Gray A, de la Luz Garcia-Hernandez M, van West M, Kanodia S, Hubby B, Kast WM. Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages. Vaccine. 27: G52-9. PMID 20006141 DOI: 10.1016/J.Vaccine.2009.09.106 |
0.596 |
|
2009 |
Koh YT, Gray A, Higgins SA, Hubby B, Kast WM. Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. The Prostate. 69: 571-84. PMID 19143030 DOI: 10.1002/Pros.20906 |
0.658 |
|
2009 |
Raff AB, Gray A, Kast WM. Prostate stem cell antigen: a prospective therapeutic and diagnostic target. Cancer Letters. 277: 126-32. PMID 18838214 DOI: 10.1016/J.Canlet.2008.08.034 |
0.569 |
|
2008 |
Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Immunological Reviews. 222: 316-27. PMID 18364011 DOI: 10.1111/J.1600-065X.2008.00605.X |
0.571 |
|
2008 |
Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Research. 68: 861-9. PMID 18245488 DOI: 10.1158/0008-5472.Can-07-0445 |
0.605 |
|
2007 |
Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Research. 67: 1344-51. PMID 17283172 DOI: 10.1158/0008-5472.Can-06-2996 |
0.572 |
|
Show low-probability matches. |